Nimotuzumab Combined With Neoadjuvant Chemotherapy in the Treatment of Resectable LA HNSCC
NCT05351762
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
55
Enrollment
OTHER
Sponsor class
Conditions
Head and Neck Squamous Cell Carcinoma
Interventions
DRUG:
Nimotuzumab Combined With Neoadjuvant Chemotherapy
Sponsor
Xijing Hospital